Optimizing LC/MS for drug bioanalysis

被引:0
|
作者
Glaser, Vicki
机构
来源
Genetic Engineering and Biotechnology News | 2012年 / 32卷 / 05期
关键词
D O I
10.1089/gen.32.5.09
中图分类号
学科分类号
摘要
引用
收藏
页码:26 / 27
相关论文
共 50 条
  • [1] Integrating automation and LC/MS for drug discovery bioanalysis
    Rossi, DT
    JOURNAL OF AUTOMATED METHODS & MANAGEMENT IN CHEMISTRY, 2002, 24 (01): : 1 - 7
  • [2] Turbulent-flow LC for LC-MS and LC-MS-MS bioanalysis
    Oberhauser, CJ
    Niggebrugge, AE
    Lachance, D
    Takarewski, JJ
    Pegram, MM
    Quinn, HM
    LC GC NORTH AMERICA, 2000, 18 (07) : 716 - +
  • [3] LC-MS/MS Bioanalysis of Radioligand Therapeutic Drug Candidate for Preclinical Toxicokinetic Assessment
    Fu, Yunlin
    Farnham, James
    Li, Wenkui
    Powers, Brendan
    Humphries, David
    Picard, Franck
    ANALYTICAL CHEMISTRY, 2023, 95 (28) : 10812 - 10819
  • [4] Micro-LC-MS/MS: the future of bioanalysis
    Arnold, Don W.
    Needham, Shane R.
    BIOANALYSIS, 2013, 5 (11) : 1329 - 1331
  • [5] Chemical derivatization as a tool for optimizing MS response in sensitive LC-MS/MS bioanalysis and its role in pharmacokinetic studies
    Niwa, Makoto
    BIOANALYSIS, 2012, 4 (02) : 213 - 220
  • [6] PATTERN-RECOGNITION AND LC/MS IN BIOANALYSIS
    VANDERGREEF, J
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 292 - 292
  • [7] Multidimensional approaches in LC and MS for phospholipid bioanalysis
    Guo, Xinghua
    Lankmayr, Ernst
    BIOANALYSIS, 2010, 2 (06) : 1109 - 1123
  • [8] Sample preparation in LC-MS bioanalysis
    Hopfgartner, Gerard
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2020, 412 (04) : 803 - 804
  • [9] LC–MS bioanalysis of intact proteins and peptides
    Jian, Wenying (wjian@its.jnj.com), 1600, John Wiley and Sons Ltd (34):
  • [10] Development and validation of an LC-MS/MS generic assay platform for small molecule drug bioanalysis
    Parise, Robert A.
    Covey, Joseph M.
    Hollingshead, Melinda G.
    Srivastava, Apurva K.
    Synold, Timothy W.
    Beumer, Jan H.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 203